Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market

In the latest trading session, UnitedHealth Group (UNH) closed at $354.50, marking a -3.59% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 2.71%. Elsewhere, the Dow saw a downswing of 1.9%, while the tech-heavy Nasdaq depreciated by 3.56%. Heading into today, shares of the largest U.S. health insurer had gained 3.98% over the past month, outpacing the Medical sector's gain of 2.6% and the S&P 500's gain of 3.5%.Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on October 28, 2025. The company's earnings per share (EPS) are projected to be $2.83, reflecting a 60.42% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $113.48 billion, reflecting a 12.55% rise from the equivalent quarter last year. For the full year, the Zacks Consensus Estimates project earnings of $16.16 per share and a revenue of $448.43 billion, demonstrating changes of -41.58% and +12.03%, respectively, from the preceding year. Investors might also notice recent changes to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 1.13% rise in the Zacks Consensus EPS estimate. UnitedHealth Group is currently a Zacks Rank #3 (Hold). Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 22.76. This denotes a premium relative to the industry average Forward P/E of 17.04. We can also see that UNH currently has a PEG ratio of 2.38. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - HMOs was holding an average PEG ratio of 1.49 at yesterday's closing price. The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 192, finds itself in the bottom 23% echelons of all 250+ industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow UNH in the coming trading sessions, be sure to utilize Zacks.com. Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks